Get started
Author

Noortje van Herwaarden

Observed names: Herwaarden, N. van, N van Herwaarden, N. Van Herwaarden, N. van Herwaarden, Noortje Van Herwaarden, van Herwaarden, N, van Herwaarden, Noortje
Observed institutions: Karolinska University Hospital, Radboud University Nijmegen, King's College London, University of Oslo, Erasmus MC, Radboud University Medical Center, Canisius-Wilhelmina Ziekenhuis, Sint Maartenskliniek, Sint Maartenskliniek
ORCID: 0000-0002-9527-851X
Observed ORCID: 0000-0002-9527-851X
OpenAlex ID: A5007213856
Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial
2015 · N. van Herwaarden, A. van der Maas, et al. · BMJ · 178
PDF
Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity
2014 · Noortje van Herwaarden, Alfons A den Broeder, et al. · Cochrane Database of Systematic Reviews · 111
Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity
2019 · Lise M Verhoef, Bart JF van den Bemt, et al. · Cochrane Database of Systematic Reviews · 82
PDF
Long-term outcomes after disease activity-guided dose reduction of TNF inhibition in rheumatoid arthritis: 3-year data of the DRESS study - a randomised controlled pragmatic non-inferiority strategy trial
2017 · Chantal AM Bouman, Noortje van Herwaarden, et al. · Annals of the Rheumatic Diseases · 52
Disease activity-guided dose optimisation of adalimumab and etanercept is a cost-effective strategy compared with non-tapering tight control rheumatoid arthritis care: analyses of the DRESS study
2016 · Wietske Kievit, Noortje van Herwaarden, et al. · Annals of the Rheumatic Diseases · 47
Dose REduction strategy of subcutaneous TNF inhibitors in rheumatoid arthritis: design of a pragmatic randomised non inferiority trial, the DRESS study
2013 · Alfons A den Broeder, Noortje van Herwaarden, et al. · BMC Musculoskeletal Disorders · 42
PDF
Predictive value of serum calprotectin (S100A8/A9) for clinical response after starting or tapering anti-TNF treatment in patients with rheumatoid arthritis
2018 · Lieke Tweehuysen, Nathan den Broeder, et al. · RMD Open · 39
PDF
Dose reduction of tocilizumab in rheumatoid arthritis patients with low disease activity.
2014 · N van Herwaarden, S Herfkens-Hol, et al. · PubMed · 31
Prediction of successful dose reduction or discontinuation of adalimumab, etanercept, or infliximab in rheumatoid arthritis patients using serum drug levels and antidrug antibody measurement
2017 · CAM Bouman, N van Herwaarden, et al. · Expert Opinion on Drug Metabolism & Toxicology · 27
A multi-biomarker score measuring disease activity in rheumatoid arthritis patients tapering adalimumab or etanercept: predictive value for clinical and radiographic outcomes
2017 · Chantal A. M. Bouman, Aatke van der Maas, et al. · Lara D. Veeken · 26
Clinical utility of therapeutic drug monitoring in biological disease modifying anti-rheumatic drug treatment of rheumatic disorders: a systematic narrative review
2017 · Noortje Van Herwaarden, Bart J.F. Van Den Bemt, et al. · Expert Opinion on Drug Metabolism & Toxicology · 25
Change of the microvascularization in systemic sclerosis, a matter of air
2021 · J.M.J. Lemmers, A. Velauthapillai, et al. · Best Practice & Research Clinical Rheumatology · 22
PDF
Therapeutic drug monitoring of biologicals in rheumatoid arthritis: a disconnect between beliefs and facts
2018 · Alfons A. den Broeder, Noortje van Herwaarden, et al. · Current Opinion in Rheumatology · 22
Therapeutic drug monitoring of adalimumab in RA: no predictive value of adalimumab serum levels and anti-adalimumab antibodies for prediction of response to the next bDMARD
2020 · Evy Ulijn, Nathan den Broeder, et al. · Annals of the Rheumatic Diseases · 20
Ab0634 Beliefs About Urate Lowering Therapy Differ Between General Practitioners and Rheumatologists
2021 · F. Veenstra, J. Vriezekolk, et al. · Annals of the Rheumatic Diseases · 19
Three-year cost-effectiveness analysis of the DRESS study: protocolised tapering is key
2018 · Nathan den Broeder, Chantal A M Bouman, et al. · Annals of the Rheumatic Diseases · 16
Adalimumab and etanercept serum (anti)drug levels are not predictive for successful dose reduction or discontinuation in rheumatoid arthritis
2015 · Noortje van Herwaarden, Chantal A M Bouman, et al. · Annals of the Rheumatic Diseases · 15
Disease activity–guided dose optimization including discontinuation of TNF inhibitors in rheumatoid arthritis is effective for up to 10 years: an observational follow-up of the DRESS study
2024 · Céleste J T van der Togt, Nathan den Broeder, et al. · Lara D. Veeken · 14
PDF
Effect of metformin use on clinical outcomes and serum urate in gout patients with diabetes mellitus: a retrospective cohort study
2022 · Frouwke Veenstra, Lise M. Verhoef, et al. · BMC Rheumatology · 14
PDF
18F-FDG PET-CT in rheumatoid arthritis patients tapering TNFi: reliability, validity and predictive value
2021 · Chantal A M Bouman, Noortje van Herwaarden, et al. · Lara D. Veeken · 12
Therapy with JAK inhibitors or bDMARDs and the risk of cardiovascular events in the Dutch rheumatoid arthritis population
2023 · Calin D Popa, Merel A A Opdam, et al. · Lara D. Veeken · 10
Sex differences in response to allopurinol and benzbromarone in gout: a retrospective cohort study
2021 · Frouwke Veenstra, Sophie A C Wanten, et al. · Rheumatology Advances in Practice · 9
Switching from prednisolone to dexamethasone in difficult-to-treat rheumatoid arthritis
2023 · Floor Kerstens, Karin Spijkers, et al. · Lara D. Veeken · 8
What causes a small increase in radiographic progression in rheumatoid arthritis patients tapering TNF inhibitors?
2017 · Chantal A M Bouman, Alfons A den Broeder, et al. · RMD Open · 7
PDF
Cycle versus swap strategy after TNFi discontinuation in psoriatic arthritis and axial spondyloarthritis: a quasi-experimental study
2025 · Ilse van Es, Johanna E Vriezekolk, et al. · RMD Open · 6
PDF
Works count: 100
Citation count: 944
H-index: 16
I10-index: 21
Year
Topic
Type